Doximity Sees Q2 Sales $170.000M-$171.000M vs $171.946M Est

Benzinga Newsdesk www.benzinga.com Positive 83.6%

Neg 0% Neu 0% Pos 83.6%

Doximity (NYSE:DOCS) sees Q2 sales of $170.000 million-$171.000 million vs $171.946 million analyst estimate.

Comments

No comments yet. Be the first!